Sumihito Nobusawa
- Genetics top 0.2%
- Molecular Biology top 5%
- Cancer Research top 2%
- Neurology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Hiroko OhgakiPaul KleihuesTakuya WatanabeHideaki YokooYoichi NakazatoJunko HiratoHayato IkotaAnne Vital
- Topics
- Glioma Diagnosis and Treatment (69 papers)Chromatin Remodeling and Cancer (24 papers)Neuroblastoma Research and Treatments (21 papers)
- Cited by
- GeneticsCancer ResearchNeurology
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEClinical Cancer Research
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Sumihito Nobusawa
108 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Genetics 2.2k
- Molecular Biology 1.3k
- Cancer Research 1.1k
- Neurology 619
- Pulmonary and Respiratory Medicine 575
Countries citing papers authored by Sumihito Nobusawa
This map shows the geographic impact of Sumihito Nobusawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumihito Nobusawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumihito Nobusawa more than expected).
Fields of papers citing papers by Sumihito Nobusawa
This network shows the impact of papers produced by Sumihito Nobusawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumihito Nobusawa. The network helps show where Sumihito Nobusawa may publish in the future.
Co-authorship network of co-authors of Sumihito Nobusawa
This figure shows the co-authorship network connecting the top 25 collaborators of Sumihito Nobusawa. A scholar is included among the top collaborators of Sumihito Nobusawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumihito Nobusawa. Sumihito Nobusawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | 6 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 16 | |
| 17 | 46 | |
| 18 | 175 | |
| 19 | 58 | |
| 20 | IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomasbreakdown → | 529 |
About Sumihito Nobusawa
Sumihito Nobusawa is a scholar working on Genetics, Neurology and Cancer Research, having authored 115 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (69 papers), Chromatin Remodeling and Cancer (24 papers) and Neuroblastoma Research and Treatments (21 papers). The work is most often cited by research in Genetics (2.2k citations), Cancer Research (1.1k citations) and Neurology (619 citations). Sumihito Nobusawa has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Hiroko Ohgaki, Paul Kleihues, Takuya Watanabe, Hideaki Yokoo, Yoichi Nakazato, Junko Hirato, Hayato Ikota, Anne Vital, Atsushi Sasaki and Young Ho Kim. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.